| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation J Xue, SV Schmidt, J Sander, A Draffehn, W Krebs, I Quester, D De Nardo, ... Immunity 40 (2), 274-288, 2014 | 2143 | 2014 |
| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1260 | 2020 |
| Western diet triggers NLRP3-dependent innate immune reprogramming A Christ, P Günther, MAR Lauterbach, P Duewell, D Biswas, K Pelka, ... Cell 172 (1), 162-175. e14, 2018 | 815 | 2018 |
| Innate immune memory in the brain shapes neurological disease hallmarks AC Wendeln, K Degenhardt, L Kaurani, M Gertig, T Ulas, G Jain, ... Nature 556 (7701), 332-338, 2018 | 732 | 2018 |
| Microbiome influences prenatal and adult microglia in a sex-specific manner MS Thion, D Low, A Silvin, J Chen, P Grisel, J Schulte-Schrepping, ... Cell 172 (3), 500-516. e16, 2018 | 674 | 2018 |
| Swarm learning for decentralized and confidential clinical machine learning S Warnat-Herresthal, H Schultze, KL Shastry, S Manamohan, ... Nature 594 (7862), 265-270, 2021 | 553 | 2021 |
| The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ... Cell 167 (5), 1145-1149, 2016 | 509 | 2016 |
| High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3 D De Nardo, LI Labzin, H Kono, R Seki, SV Schmidt, M Beyer, D Xu, ... Nature immunology 15 (2), 152-160, 2014 | 442 | 2014 |
| Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1 E Vacchelli, Y Ma, EE Baracco, A Sistigu, DP Enot, F Pietrocola, H Yang, ... Science 350 (6263), 972-978, 2015 | 431 | 2015 |
| Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming S Zimmer, A Grebe, SS Bakke, N Bode, B Halvorsen, T Ulas, M Skjelland, ... Science translational medicine 8 (333), 333ra50-333ra50, 2016 | 337 | 2016 |
| Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression P Goossens, J Rodriguez-Vita, A Etzerodt, M Masse, O Rastoin, ... Cell metabolism 29 (6), 1376-1389. e4, 2019 | 301 | 2019 |
| Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ... Immunity 53 (6), 1296-1314. e9, 2020 | 297 | 2020 |
| A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice A Bilkei-Gorzo, O Albayram, A Draffehn, K Michel, A Piyanova, ... Nature medicine 23 (6), 782, 2017 | 253 | 2017 |
| Transcriptional profiling of human microglia reveals grey–white matter heterogeneity and multiple sclerosis-associated changes M van der Poel, T Ulas, MR Mizee, CC Hsiao, SSM Miedema, null Adelia, ... Nature communications 10 (1), 1139, 2019 | 237 | 2019 |
| Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients AC Aschenbrenner, M Mouktaroudi, B Krämer, M Oestreich, N Antonakos, ... Genome medicine 13, 1-25, 2021 | 227 | 2021 |
| The calcium channel subunit Alpha2delta2 suppresses axon regeneration in the adult CNS A Tedeschi, S Dupraz, CJ Laskowski, J Xue, T Ulas, M Beyer, JL Schultze, ... Neuron 92 (2), 419-434, 2016 | 225 | 2016 |
| Epigenomic profiling of human CD4+ T cells supports a linear differentiation model and highlights molecular regulators of memory development P Durek, K Nordström, G Gasparoni, A Salhab, C Kressler, M De Almeida, ... Immunity 45 (5), 1148-1161, 2016 | 196 | 2016 |
| Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, ... Immunity 54 (11), 2650-2669. e14, 2021 | 169 | 2021 |
| Cellular differentiation of human monocytes is regulated by time-dependent interleukin-4 signaling and the transcriptional regulator NCOR2 J Sander, SV Schmidt, B Cirovic, N McGovern, O Papantonopoulou, ... Immunity 47 (6), 1051-1066. e12, 2017 | 161 | 2017 |
| Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response C Salvagno, M Ciampricotti, S Tuit, CS Hau, A van Weverwijk, SB Coffelt, ... Nature cell biology 21 (4), 511-521, 2019 | 147 | 2019 |
